[HTML][HTML] Evolution of SARS-CoV-2 variants: implications on immune escape, vaccination, therapeutic and diagnostic strategies

NZ Zabidi, HL Liew, IA Farouk, A Puniyamurti, AJW Yip… - Viruses, 2023 - mdpi.com
The COVID-19 pandemic caused by SARS-CoV-2 is associated with a lower fatality rate
than its SARS and MERS counterparts. However, the rapid evolution of SARS-CoV-2 has …

[HTML][HTML] Omicron variant evolution on vaccines and monoclonal antibodies

M Sabbatucci, A Vitiello, S Clemente, A Zovi… - …, 2023 - Springer
The severe acute respiratory syndrome coronavirus (SARS-CoV)-2 responsible for the
global COVID-19 pandemic has caused almost 760 million confirmed cases and 7 million …

[HTML][HTML] Booster with Ad26. COV2. S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques

L Solforosi, LMM Costes, JTBM Tolboom… - Nature …, 2023 - nature.com
Omicron spike (S) encoding vaccines as boosters, are a potential strategy to improve COVID-
19 vaccine efficacy against Omicron. Here, macaques (mostly females) previously …

[HTML][HTML] The latest Omicron BA. 4 and BA. 5 lineages are frowning toward COVID‐19 preventive measures: a threat to global public health

MR Islam, M Shahriar, MA Bhuiyan - Health science reports, 2022 - ncbi.nlm.nih.gov
1. BACKGROUND A cluster of pneumonia cases was reported by the Wuhan Municipal
Health Commission, China, Hubei Province, resulting in the identification of a novel …

[HTML][HTML] The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages

T Xiang, J Wang, X Zheng - Virologica Sinica, 2022 - Elsevier
The recently discovered SARS-CoV-2 variant Omicron (B. 1.1. 529) has rapidly become a
global public health issue. The substantial mutations in the spike protein in this new variant …

Cases of BA. 2.75 and recent BA. 2.75. 2 subvariant of Omicron are increasing in India: Is it alarming at the global level?

C Chakraborty, M Bhattacharya… - Annals of Medicine and …, 2022 - journals.lww.com
Global tracking of BA. 2.75. 2 is immediately required as earlier BA. 2.75 replaced BA. 4 and
BA. 5 subvariants, and now BA. 2.75. 2 is rather comparatively more transmissible, therefore …

Could the new BA. 2.75 sub-variant cause the emergence of a global epidemic of COVID-19? A scoping review

N Shaheen, A Mohamed, A Attalla… - Infection and Drug …, 2022 - Taylor & Francis
With over 58 million cases and 6 million deaths by August 2022, the Coronavirus disease
2019 (COVID-19), causing severe acute respiratory syndrome coronavirus 2 (SARs-CoV-2) …

Efficacy of therapeutic plasma exchange in patients with severe COVID‐19: A systematic review and meta‐analysis

OA Abdelwahab, RA Diab, KS Elsaeidy… - Reviews in Medical …, 2023 - Wiley Online Library
We conducted this systematic review and meta‐analysis to evaluate the existing evidence
and to quantitatively synthesise evidence on the impact of therapeutic plasma exchange …

[HTML][HTML] Omicron BA. 2.75 variant is efficiently neutralised following BA. 1 and BA. 5 breakthrough infection in vaccinated individuals, Israel, June to September 2022

N Atari, L Kliker, N Zuckerman, B Abd Elkader… - …, 2022 - eurosurveillance.org
We evaluated neutralising antibody titres against wild type (WT) SARS-CoV-2 and four
Omicron variants (BA. 1, BA. 2, BA. 5 and BA. 2.75) in fully vaccinated (three doses of …

The 249RWMD spike protein insertion in Omicron BQ. 1 subvariant compensates the 24LPP and 69HV deletions and may cause severe disease than BF. 7 and XBB …

AK CHAKRABORTY - 2023 - researchsquare.com
Alarming antibody evasion properties were documented for new BF, BQ and XBB Omicron
subvariants. Most immune-drugs were inactive neutralizing those COVID-19 subvariants …